_id
691483e7ccc777a4e85d94a8
Ticker
NRSN
Name
Neurosense Therapeutics Ltd
Exchange
NASDAQ
Address
Building B, Herzliya, Israel, 4672562
Country
USA
Sector
Healthcare
Industry
Biotechnology
Currency
USD
Website
https://www.neurosense-tx.com
Description
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. The company was incorporated in 2017 and is headquartered in Herzliya, Israel.
Last Close
0.89
Volume
166866
Current Price
0.89
Change
0
Last Updated
2025-12-02T12:42:54.392Z
Image
data:image/webp;base64,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
Ipo Date
2021-12-09T00:00:00.000Z
Market Cap
27113016
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Rating
4.3333
Target Price
11.5
Strong Buy
2
Buy
0
Hold
1
Sell
0
Strong Sell
0
Current Quarter
2025-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
2346000
Operating Income
-2346000
Interest Expense
8500
Pretax Income
-2354500
Net Income
-2354500
Eps
-0.09268718392321998
Dividends Per Share
-
Shares Outstanding
29550970
Income Tax Expense
-
EBITDA
-2342000
Operating Margin
-
Total Other Income Expense Net
-8500
Cash
666000
Short Term Investments
-
Receivables
847000
Inventories
-
Total Current Assets
1556000
Property Plant Equipment
105000
Total Assets
1684000
Payables
1093000
Short Term Debt
-
Long Term Debt
-
Total Liabilities
2203000
Equity
-519000
Depreciation
4
Change In Working Capital
231
Cash From Operations
-2000
Capital Expenditures
0
Cash From Investing
-6.5
Cash From Financing
650.5
Net Change In Cash
-
PE
-
PB
-43.56138267822736
ROE
453.6608863198459
ROA
-139.81591448931115
FCF
-2000
Fcf Percent
-
Piotroski FScore
1
Health Score
39
Deep Value Investing Score
0.5
Defensive Investing Score
6
Dividend Investing Score
1.5
Economic Moat Investing Score
4.8
Garp Investing Score
2
Growth Investing Score
2
Momentum Investing Score
2
Net Net Investing Score
0.5
Quality Investing Score
2.5
Value Investing Score
3
Quarters > 0 > quarter
2025-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
2346000
Quarters > 0 > income Statement > operating Income
-2346000
Quarters > 0 > income Statement > interest Expense
8500
Quarters > 0 > income Statement > pretax Income
-2354500
Quarters > 0 > income Statement > net Income
-2354500
Quarters > 0 > income Statement > eps
-0.09268718392321998
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
25402649
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-2342000
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-8500
Quarters > 0 > balance Sheet > cash
666000
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
847000
Quarters > 0 > balance Sheet > inventories
-
Quarters > 0 > balance Sheet > total Current Assets
1556000
Quarters > 0 > balance Sheet > property Plant Equipment
105000
Quarters > 0 > balance Sheet > total Assets
1684000
Quarters > 0 > balance Sheet > payables
1093000
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
2203000
Quarters > 0 > balance Sheet > equity
-519000
Quarters > 0 > cash Flow > net Income
-2354.5
Quarters > 0 > cash Flow > depreciation
4
Quarters > 0 > cash Flow > change In Working Capital
231
Quarters > 0 > cash Flow > cash From Operations
-2000
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-6.5
Quarters > 0 > cash Flow > cash From Financing
650.5
Quarters > 0 > cash Flow > net Change In Cash
-
Quarters > 0 > ratios > PE
-0.09268718392321998
Quarters > 0 > ratios > PB
-43.56138267822736
Quarters > 0 > ratios > ROE
453.6608863198459
Quarters > 0 > ratios > ROA
-139.81591448931115
Quarters > 0 > ratios > FCF
-2000
Quarters > 0 > ratios > Piotroski FScore
1
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
39
Quarters > 1 > quarter
2025-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
2346000
Quarters > 1 > income Statement > operating Income
-2346000
Quarters > 1 > income Statement > interest Expense
8500
Quarters > 1 > income Statement > pretax Income
-2354500
Quarters > 1 > income Statement > net Income
-2354500
Quarters > 1 > income Statement > eps
-0.09268718392321998
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
25402649
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-2342000
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-8500
Quarters > 1 > balance Sheet > cash
666000
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
164000
Quarters > 1 > balance Sheet > inventories
-
Quarters > 1 > balance Sheet > total Current Assets
1556000
Quarters > 1 > balance Sheet > property Plant Equipment
105000
Quarters > 1 > balance Sheet > total Assets
1684000
Quarters > 1 > balance Sheet > payables
1093000
Quarters > 1 > balance Sheet > short Term Debt
146000
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
2203000
Quarters > 1 > balance Sheet > equity
-519000
Quarters > 1 > cash Flow > net Income
-2354.5
Quarters > 1 > cash Flow > depreciation
4
Quarters > 1 > cash Flow > change In Working Capital
231
Quarters > 1 > cash Flow > cash From Operations
-2000
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-6.5
Quarters > 1 > cash Flow > cash From Financing
650.5
Quarters > 1 > cash Flow > net Change In Cash
-
Quarters > 1 > ratios > PE
-0.09268718392321998
Quarters > 1 > ratios > PB
-43.56138267822736
Quarters > 1 > ratios > ROE
453.6608863198459
Quarters > 1 > ratios > ROA
-139.81591448931115
Quarters > 1 > ratios > FCF
-2000
Quarters > 1 > ratios > Piotroski FScore
1
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
39
Quarters > 2 > quarter
2024-12-31
Quarters > 2 > income Statement > revenue
0
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
1771000
Quarters > 2 > income Statement > operating Income
-1771000
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-1801000
Quarters > 2 > income Statement > net Income
-1801000
Quarters > 2 > income Statement > eps
-0.07753259177850597
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
23228941
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > balance Sheet > cash
3378000
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
-
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
4402000
Quarters > 2 > balance Sheet > property Plant Equipment
150000
Quarters > 2 > balance Sheet > total Assets
4575000
Quarters > 2 > balance Sheet > payables
1160000
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
1992000
Quarters > 2 > balance Sheet > equity
2583000
Quarters > 2 > cash Flow > net Income
-1801000
Quarters > 2 > cash Flow > depreciation
-
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-
Quarters > 2 > cash Flow > capital Expenditures
0
Quarters > 2 > cash Flow > cash From Investing
-
Quarters > 2 > cash Flow > cash From Financing
-
Quarters > 2 > cash Flow > net Change In Cash
-
Quarters > 2 > ratios > PE
-0.07753259177850597
Quarters > 2 > ratios > PB
8.003777580332946
Quarters > 2 > ratios > ROE
-69.72512582268679
Quarters > 2 > ratios > ROA
-39.36612021857924
Quarters > 2 > ratios > FCF
-
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
30
Quarters > 3 > quarter
2024-09-30
Quarters > 3 > income Statement > revenue
0
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
2107000
Quarters > 3 > income Statement > operating Income
-2107000
Quarters > 3 > income Statement > interest Expense
41000
Quarters > 3 > income Statement > pretax Income
-2148000
Quarters > 3 > income Statement > net Income
-2148000
Quarters > 3 > income Statement > eps
-0.10843555959412389
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
19809000
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-2101750
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-41000
Quarters > 3 > balance Sheet > cash
344000
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
406000
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
785000
Quarters > 3 > balance Sheet > property Plant Equipment
176000
Quarters > 3 > balance Sheet > total Assets
984000
Quarters > 3 > balance Sheet > payables
1392000
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3802000
Quarters > 3 > balance Sheet > equity
-2818000
Quarters > 3 > cash Flow > net Income
-2148
Quarters > 3 > cash Flow > depreciation
5250
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-
Quarters > 3 > cash Flow > capital Expenditures
0
Quarters > 3 > cash Flow > cash From Investing
-
Quarters > 3 > cash Flow > cash From Financing
-
Quarters > 3 > cash Flow > net Change In Cash
-
Quarters > 3 > ratios > PE
-0.10843555959412389
Quarters > 3 > ratios > PB
-6.256213626685593
Quarters > 3 > ratios > ROE
76.22427253371185
Quarters > 3 > ratios > ROA
-218.2926829268293
Quarters > 3 > ratios > FCF
-
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
38
Annuals > 0 > quarter
2024-12-31
Annuals > 0 > income Statement > revenue
0
Annuals > 0 > income Statement > cost Of Revenue
22000
Annuals > 0 > income Statement > gross Profit
-22000
Annuals > 0 > income Statement > operating Expenses
9880000
Annuals > 0 > income Statement > operating Income
-9902000
Annuals > 0 > income Statement > interest Expense
311000
Annuals > 0 > income Statement > pretax Income
-10210000
Annuals > 0 > income Statement > net Income
-10210000
Annuals > 0 > income Statement > eps
-0.5488657133641544
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
18602000
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-9877000
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-308000
Annuals > 0 > balance Sheet > cash
3378000
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
164000
Annuals > 0 > balance Sheet > inventories
-
Annuals > 0 > balance Sheet > total Current Assets
4402000
Annuals > 0 > balance Sheet > property Plant Equipment
150000
Annuals > 0 > balance Sheet > total Assets
4575000
Annuals > 0 > balance Sheet > payables
1160000
Annuals > 0 > balance Sheet > short Term Debt
146000
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
1992000
Annuals > 0 > balance Sheet > equity
2583000
Annuals > 0 > cash Flow > net Income
-10210000
Annuals > 0 > cash Flow > depreciation
22000
Annuals > 0 > cash Flow > change In Working Capital
-781000
Annuals > 0 > cash Flow > cash From Operations
-10135000
Annuals > 0 > cash Flow > capital Expenditures
3000
Annuals > 0 > cash Flow > cash From Investing
1000
Annuals > 0 > cash Flow > cash From Financing
10913000
Annuals > 0 > cash Flow > net Change In Cash
738000
Annuals > 0 > ratios > PE
-0.5488657133641544
Annuals > 0 > ratios > PB
8.425993031358884
Annuals > 0 > ratios > ROE
-395.2768099109563
Annuals > 0 > ratios > ROA
-223.16939890710384
Annuals > 0 > ratios > FCF
-10138000
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
22
Annuals > 1 > quarter
2023-12-31
Annuals > 1 > income Statement > revenue
0
Annuals > 1 > income Statement > cost Of Revenue
97000
Annuals > 1 > income Statement > gross Profit
-97000
Annuals > 1 > income Statement > operating Expenses
12049000
Annuals > 1 > income Statement > operating Income
-12049000
Annuals > 1 > income Statement > interest Expense
550000
Annuals > 1 > income Statement > pretax Income
-11280000
Annuals > 1 > income Statement > net Income
-10107000
Annuals > 1 > income Statement > eps
-0.7409824046920821
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
13640000
Annuals > 1 > income Statement > income Tax Expense
-1
Annuals > 1 > income Statement > EBITDA
-9638000
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
1942000
Annuals > 1 > balance Sheet > cash
2640000
Annuals > 1 > balance Sheet > short Term Investments
0
Annuals > 1 > balance Sheet > receivables
166000
Annuals > 1 > balance Sheet > inventories
-
Annuals > 1 > balance Sheet > total Current Assets
2916000
Annuals > 1 > balance Sheet > property Plant Equipment
238000
Annuals > 1 > balance Sheet > total Assets
3176000
Annuals > 1 > balance Sheet > payables
1459000
Annuals > 1 > balance Sheet > short Term Debt
138000
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
4944000
Annuals > 1 > balance Sheet > equity
-1874000
Annuals > 1 > cash Flow > net Income
-10107000
Annuals > 1 > cash Flow > depreciation
21000
Annuals > 1 > cash Flow > change In Working Capital
1908000
Annuals > 1 > cash Flow > cash From Operations
-8354000
Annuals > 1 > cash Flow > capital Expenditures
29000
Annuals > 1 > cash Flow > cash From Investing
3468000
Annuals > 1 > cash Flow > cash From Financing
3975000
Annuals > 1 > cash Flow > net Change In Cash
-903000
Annuals > 1 > ratios > PE
-0.7409824046920821
Annuals > 1 > ratios > PB
-8.51590181430096
Annuals > 1 > ratios > ROE
539.3276414087513
Annuals > 1 > ratios > ROA
-318.2304785894206
Annuals > 1 > ratios > FCF
-8383000
Annuals > 1 > ratios > Piotroski FScore
1
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
31
Annuals > 2 > quarter
2022-12-31
Annuals > 2 > income Statement > revenue
0
Annuals > 2 > income Statement > cost Of Revenue
89000
Annuals > 2 > income Statement > gross Profit
-89000
Annuals > 2 > income Statement > operating Expenses
13463000
Annuals > 2 > income Statement > operating Income
-13552000
Annuals > 2 > income Statement > interest Expense
15000
Annuals > 2 > income Statement > pretax Income
-12340000
Annuals > 2 > income Statement > net Income
-12340000
Annuals > 2 > income Statement > eps
-1.0725771403737505
Annuals > 2 > income Statement > dividends Per Share
-
Annuals > 2 > income Statement > shares Outstanding
11505000
Annuals > 2 > income Statement > income Tax Expense
-1143000
Annuals > 2 > income Statement > EBITDA
-12229000
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
1212000
Annuals > 2 > balance Sheet > cash
3543000
Annuals > 2 > balance Sheet > short Term Investments
3547000
Annuals > 2 > balance Sheet > receivables
131000
Annuals > 2 > balance Sheet > inventories
-3678000
Annuals > 2 > balance Sheet > total Current Assets
7381000
Annuals > 2 > balance Sheet > property Plant Equipment
306000
Annuals > 2 > balance Sheet > total Assets
7710000
Annuals > 2 > balance Sheet > payables
498000
Annuals > 2 > balance Sheet > short Term Debt
128000
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
2091000
Annuals > 2 > balance Sheet > equity
5619000
Annuals > 2 > cash Flow > net Income
-12340000
Annuals > 2 > cash Flow > depreciation
89000
Annuals > 2 > cash Flow > change In Working Capital
750000
Annuals > 2 > cash Flow > cash From Operations
-7586000
Annuals > 2 > cash Flow > capital Expenditures
70000
Annuals > 2 > cash Flow > cash From Investing
-3541000
Annuals > 2 > cash Flow > cash From Financing
3695000
Annuals > 2 > cash Flow > net Change In Cash
-7520000
Annuals > 2 > ratios > PE
-1.0725771403737505
Annuals > 2 > ratios > PB
2.395595301655099
Annuals > 2 > ratios > ROE
-219.61203061042892
Annuals > 2 > ratios > ROA
-160.05188067444877
Annuals > 2 > ratios > FCF
-7656000
Annuals > 2 > ratios > Piotroski FScore
1
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
35
Annuals > 3 > quarter
2021-12-31
Annuals > 3 > income Statement > revenue
0
Annuals > 3 > income Statement > cost Of Revenue
3000
Annuals > 3 > income Statement > gross Profit
-3000
Annuals > 3 > income Statement > operating Expenses
5587000
Annuals > 3 > income Statement > operating Income
-5587000
Annuals > 3 > income Statement > interest Expense
1154000
Annuals > 3 > income Statement > pretax Income
-4041000
Annuals > 3 > income Statement > net Income
-4041000
Annuals > 3 > income Statement > eps
-0.3722365512159175
Annuals > 3 > income Statement > dividends Per Share
-
Annuals > 3 > income Statement > shares Outstanding
10856000
Annuals > 3 > income Statement > income Tax Expense
-1546000
Annuals > 3 > income Statement > EBITDA
-2884000
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
1546000
Annuals > 3 > balance Sheet > cash
11063000
Annuals > 3 > balance Sheet > short Term Investments
0
Annuals > 3 > balance Sheet > receivables
178000
Annuals > 3 > balance Sheet > inventories
-178000
Annuals > 3 > balance Sheet > total Current Assets
11412000
Annuals > 3 > balance Sheet > property Plant Equipment
19000
Annuals > 3 > balance Sheet > total Assets
11431000
Annuals > 3 > balance Sheet > payables
39000
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
2425000
Annuals > 3 > balance Sheet > equity
9006000
Annuals > 3 > cash Flow > net Income
-4041000
Annuals > 3 > cash Flow > depreciation
3000
Annuals > 3 > cash Flow > change In Working Capital
273000
Annuals > 3 > cash Flow > cash From Operations
-1539000
Annuals > 3 > cash Flow > capital Expenditures
17000
Annuals > 3 > cash Flow > cash From Investing
-17000
Annuals > 3 > cash Flow > cash From Financing
11902000
Annuals > 3 > cash Flow > net Change In Cash
10364000
Annuals > 3 > ratios > PE
-0.3722365512159175
Annuals > 3 > ratios > PB
1.4103397734843437
Annuals > 3 > ratios > ROE
-44.87008660892739
Annuals > 3 > ratios > ROA
-35.35123786195433
Annuals > 3 > ratios > FCF
-1556000
Annuals > 3 > ratios > Piotroski FScore
0
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
34
Valuation > metrics > PE
-0.09268718392321998
Valuation > metrics > PB
-43.56138267822736
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > metrics > ROE
453.6608863198459
Profitability > metrics > ROA
-151.31748071979433
Profitability > final Score
55
Profitability > verdict
Weak
Risk > metrics > Interest Coverage
-276
Risk > final Score
-1074
Risk > verdict
High
Liquidity > metrics > Current Ratio
1.4236047575480328
Liquidity > metrics > Quick Ratio
1.4236047575480328
Liquidity > final Score
86
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
20
Prev Valuations > 2
50
Prev Profitabilities > 0
55
Prev Profitabilities > 1
15
Prev Profitabilities > 2
55
Prev Risks > 0
-1074
Prev Risks > 1
68
Prev Risks > 2
-176
Prev Liquidities > 0
81
Prev Liquidities > 1
100
Prev Liquidities > 2
38
Updated At
2025-12-14T00:55:57.731Z
Earnings History > 0 > period
2025-12-31
Earnings History > 0 > report Date
2026-03-25
Earnings History > 0 > date
2025-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
-
Earnings History > 0 > eps Actual
0
Earnings History > 0 > eps Estimate
-0.0458
Earnings History > 0 > eps Difference
0.0458
Earnings History > 0 > surprise Percent
100
Earnings History > 1 > period
2025-09-30
Earnings History > 1 > report Date
2025-11-26
Earnings History > 1 > date
2025-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
-
Earnings History > 1 > eps Actual
0
Earnings History > 1 > eps Estimate
-0.055
Earnings History > 1 > eps Difference
0.055
Earnings History > 1 > surprise Percent
100
Earnings History > 2 > period
2025-06-30
Earnings History > 2 > report Date
2025-08-01
Earnings History > 2 > date
2025-06-30
Earnings History > 2 > before After Market
-
Earnings History > 2 > currency
-
Earnings History > 2 > eps Actual
-0.19
Earnings History > 2 > eps Estimate
-0.225
Earnings History > 2 > eps Difference
0.035
Earnings History > 2 > surprise Percent
15.5556
Earnings History > 3 > period
2025-03-31
Earnings History > 3 > report Date
2025-04-07
Earnings History > 3 > date
2025-03-31
Earnings History > 3 > before After Market
AfterMarket
Earnings History > 3 > currency
-
Earnings History > 3 > eps Actual
-0.06
Earnings History > 3 > eps Estimate
-0.15
Earnings History > 3 > eps Difference
0.09
Earnings History > 3 > surprise Percent
60
Earnings History > 4 > period
2024-12-31
Earnings History > 4 > report Date
2024-12-31
Earnings History > 4 > date
2024-12-31
Earnings History > 4 > before After Market
-
Earnings History > 4 > currency
-
Earnings History > 4 > eps Actual
-0.06
Earnings History > 4 > eps Estimate
-0.15
Earnings History > 4 > eps Difference
0.09
Earnings History > 4 > surprise Percent
60
Earnings History > 5 > period
2024-09-30
Earnings History > 5 > report Date
2024-12-18
Earnings History > 5 > date
2024-09-30
Earnings History > 5 > before After Market
BeforeMarket
Earnings History > 5 > currency
USD
Earnings History > 5 > eps Actual
-0.11
Earnings History > 5 > eps Estimate
-0.11
Earnings History > 5 > eps Difference
0
Earnings History > 5 > surprise Percent
0
Earnings History > 6 > period
2024-06-30
Earnings History > 6 > report Date
2024-08-28
Earnings History > 6 > date
2024-06-30
Earnings History > 6 > before After Market
-
Earnings History > 6 > currency
USD
Earnings History > 6 > eps Actual
-0.05
Earnings History > 6 > eps Estimate
-0.185
Earnings History > 6 > eps Difference
0.135
Earnings History > 6 > surprise Percent
72.973
Earnings History > 7 > period
2024-03-31
Earnings History > 7 > report Date
2024-06-24
Earnings History > 7 > date
2024-03-31
Earnings History > 7 > before After Market
BeforeMarket
Earnings History > 7 > currency
USD
Earnings History > 7 > eps Actual
-0.35
Earnings History > 7 > eps Estimate
-0.2
Earnings History > 7 > eps Difference
-0.15
Earnings History > 7 > surprise Percent
-75
Earnings History > 8 > period
2023-12-31
Earnings History > 8 > report Date
2024-03-29
Earnings History > 8 > date
2023-12-31
Earnings History > 8 > before After Market
BeforeMarket
Earnings History > 8 > currency
USD
Earnings History > 8 > eps Actual
-0.16
Earnings History > 8 > eps Estimate
-0.2
Earnings History > 8 > eps Difference
0.04
Earnings History > 8 > surprise Percent
20
Earnings History > 9 > period
2023-09-30
Earnings History > 9 > report Date
2023-11-28
Earnings History > 9 > date
2023-09-30
Earnings History > 9 > before After Market
BeforeMarket
Earnings History > 9 > currency
USD
Earnings History > 9 > eps Actual
0.1
Earnings History > 9 > eps Estimate
-0.24
Earnings History > 9 > eps Difference
0.34
Earnings History > 9 > surprise Percent
141.6667
Earnings History > 10 > period
2023-06-30
Earnings History > 10 > report Date
2023-08-16
Earnings History > 10 > date
2023-06-30
Earnings History > 10 > before After Market
BeforeMarket
Earnings History > 10 > currency
USD
Earnings History > 10 > eps Actual
-0.44
Earnings History > 10 > eps Estimate
-0.28
Earnings History > 10 > eps Difference
-0.16
Earnings History > 10 > surprise Percent
-57.1429
Earnings History > 11 > period
2023-03-31
Earnings History > 11 > report Date
2023-06-01
Earnings History > 11 > date
2023-03-31
Earnings History > 11 > before After Market
BeforeMarket
Earnings History > 11 > currency
USD
Earnings History > 11 > eps Actual
-0.33
Earnings History > 11 > eps Estimate
-0.29
Earnings History > 11 > eps Difference
-0.04
Earnings History > 11 > surprise Percent
-13.7931
Earnings History > 12 > period
2022-12-31
Earnings History > 12 > report Date
2023-03-22
Earnings History > 12 > date
2022-12-31
Earnings History > 12 > before After Market
BeforeMarket
Earnings History > 12 > currency
USD
Earnings History > 12 > eps Actual
-0.28
Earnings History > 12 > eps Estimate
-0.28
Earnings History > 12 > eps Difference
0
Earnings History > 12 > surprise Percent
0
Earnings History > 13 > period
2022-09-30
Earnings History > 13 > report Date
2022-12-01
Earnings History > 13 > date
2022-09-30
Earnings History > 13 > before After Market
BeforeMarket
Earnings History > 13 > currency
USD
Earnings History > 13 > eps Actual
-0.26
Earnings History > 13 > eps Estimate
-0.28
Earnings History > 13 > eps Difference
0.02
Earnings History > 13 > surprise Percent
7.1429
Earnings History > 14 > period
2022-06-30
Earnings History > 14 > report Date
2022-08-31
Earnings History > 14 > date
2022-06-30
Earnings History > 14 > before After Market
BeforeMarket
Earnings History > 14 > currency
USD
Earnings History > 14 > eps Actual
-0.3
Earnings History > 14 > eps Estimate
-0.28
Earnings History > 14 > eps Difference
-0.02
Earnings History > 14 > surprise Percent
-7.1429
Earnings History > 15 > period
2022-03-31
Earnings History > 15 > report Date
2022-05-31
Earnings History > 15 > date
2022-03-31
Earnings History > 15 > before After Market
BeforeMarket
Earnings History > 15 > currency
USD
Earnings History > 15 > eps Actual
-0.24
Earnings History > 15 > eps Estimate
-0.18
Earnings History > 15 > eps Difference
-0.06
Earnings History > 15 > surprise Percent
-33.3333
Earnings History > 16 > period
2021-12-31
Earnings History > 16 > report Date
2022-03-02
Earnings History > 16 > date
2021-12-31
Earnings History > 16 > before After Market
-
Earnings History > 16 > currency
USD
Earnings History > 16 > eps Actual
-0.16
Earnings History > 16 > eps Estimate
-0.16
Earnings History > 16 > eps Difference
0
Earnings History > 16 > surprise Percent
0
Earnings History > 17 > period
2021-09-30
Earnings History > 17 > report Date
2021-12-10
Earnings History > 17 > date
2021-09-30
Earnings History > 17 > before After Market
BeforeMarket
Earnings History > 17 > currency
USD
Earnings History > 17 > eps Actual
-0.25
Earnings History > 17 > eps Estimate
-0.21
Earnings History > 17 > eps Difference
-0.04
Earnings History > 17 > surprise Percent
-19.0476
Earnings History > 18 > period
2021-03-31
Earnings History > 18 > report Date
2021-06-30
Earnings History > 18 > date
2021-03-31
Earnings History > 18 > before After Market
-
Earnings History > 18 > currency
USD
Earnings History > 18 > eps Actual
-0.2695
Earnings History > 18 > eps Estimate
0
Earnings History > 18 > eps Difference
-0.2695
Earnings History > 18 > surprise Percent
-
Earnings History > 19 > period
2020-12-31
Earnings History > 19 > report Date
2021-03-31
Earnings History > 19 > date
2020-12-31
Earnings History > 19 > before After Market
-
Earnings History > 19 > currency
USD
Earnings History > 19 > eps Actual
-0.2695
Earnings History > 19 > eps Estimate
0
Earnings History > 19 > eps Difference
-0.2695
Earnings History > 19 > surprise Percent
-
Earnings History > 20 > period
2020-09-30
Earnings History > 20 > report Date
2020-12-31
Earnings History > 20 > date
2020-09-30
Earnings History > 20 > before After Market
-
Earnings History > 20 > currency
USD
Earnings History > 20 > eps Actual
-0.1975
Earnings History > 20 > eps Estimate
0
Earnings History > 20 > eps Difference
-0.1975
Earnings History > 20 > surprise Percent
-
Earnings History > 21 > period
2020-06-30
Earnings History > 21 > report Date
2020-09-30
Earnings History > 21 > date
2020-06-30
Earnings History > 21 > before After Market
-
Earnings History > 21 > currency
USD
Earnings History > 21 > eps Actual
-0.1975
Earnings History > 21 > eps Estimate
0
Earnings History > 21 > eps Difference
-0.1975
Earnings History > 21 > surprise Percent
-
Earnings History > 22 > period
2020-03-31
Earnings History > 22 > report Date
2020-06-30
Earnings History > 22 > date
2020-03-31
Earnings History > 22 > before After Market
-
Earnings History > 22 > currency
USD
Earnings History > 22 > eps Actual
-0.057
Earnings History > 22 > eps Estimate
0
Earnings History > 22 > eps Difference
-0.057
Earnings History > 22 > surprise Percent
-
Earnings History > 23 > period
2019-12-31
Earnings History > 23 > report Date
2020-03-31
Earnings History > 23 > date
2019-12-31
Earnings History > 23 > before After Market
-
Earnings History > 23 > currency
USD
Earnings History > 23 > eps Actual
-0.057
Earnings History > 23 > eps Estimate
0
Earnings History > 23 > eps Difference
-0.057
Earnings History > 23 > surprise Percent
-
NeuroSense Therapeutics Ltd., a clinical-stage biotechnology company, focuses on discovering and developing treatments for patients suffering from debilitating neurodegenerative diseases in the United States and internationally. The company's lead product is PrimeC, an extended-release oral formulation of a fixed-dose combination of ciprofloxacin and celecoxib, currently under Phase 2b/3 clinical trials for the treatment of amyotrophic lateral sclerosis, and completed Phase 2 clinical trials for the treatment of Alzheimer's, as well as under preclinical studies for the treatment of Parkinson's disease. Its preclinical pipeline includes StabiliC for the treatment of Parkinson's disease; and CogniC for the treatment of Alzheimer's disease. The company was incorporated in 2017 and is headquartered in Herzliya, Israel.
Stock Price
$ 0.00
0% decrease compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A$NRSN Q3 2025 Earnings Preview: Recent $NRSN Insider Trading, Hedge Fund Activity, and More Quiver Quantitative
Read more →Wall Street Zen Downgrades NeuroSense Therapeutics (NASDAQ:NRSN) to Sell Defense World
Read more →Showing 2 of 10
(Last Updated 2025-06-30)
Rating:
BUY
Target Price:
$11.5
Analyst Picks
Strong Buy
2
Buy
0
Hold
1
Sell
0
Strong Sell
0
(Last Updated 2025-06-30)
Health Score
Price to Book Ratio (P/B)
-
Very Low
Low ≤ 1
High ≥ 3
Return on Equity (ROE)
-
Very High
Low ≤ 5%
High ≥ 25%
Return on Assets (ROA)
-
Very Low
Low ≤ 2%
High ≥ 10%
* Institutions hold a combined 1.75% of the total shares of Neurosense Therapeutics Ltd
1.
Citadel Advisors Llc(0.5959%)
since
2025/06/30
2.
Morgan Stanley - Brokerage Accounts(0.319%)
since
2025/06/30
3.
Squarepoint Ops LLC(0.1994%)
since
2025/06/30
4.
Meitav Dash Investments Ltd(0.1597%)
since
2025/06/30
5.
Jane Street Group LLC(0.1146%)
since
2025/06/30
6.
HRT FINANCIAL LLC(0.0866%)
since
2025/06/30
7.
Commonwealth Equity Services Inc(0.0842%)
since
2025/06/30
8.
Geode Capital Management, LLC(0.0634%)
since
2025/06/30
9.
Fidelity Nasdaq Composite Index(0.0634%)
since
2025/07/31
10.
BNP Paribas Arbitrage, SA(0.0272%)
since
2025/06/30
11.
Hurley Capital, LLC(0.0261%)
since
2025/06/30
12.
UBS Group AG(0.0064%)
since
2025/06/30
13.
CWM, LLC duplicate(0.004%)
since
2025/06/30
14.
Total Investment Management Inc(0.002%)
since
2025/06/30
15.
Warberg Asset Management LLC(0%)
since
2025/06/30
16.
Stratos Wealth Partners, LTD(0%)
since
2025/03/31
17.
XTX Topco Ltd(0%)
since
2025/06/30
18.
TWO SIGMA SECURITIES, LLC(0%)
since
2025/06/30
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
2025-12-31
EPS Estimate
-0.0458
Date
2025-09-30
EPS Actual
0
EPS Estimate
-0.055
EPS Difference
0.055
Surprise Percent
100%
(Last Updated 2025-06-30)
(Last Updated 2025-06-30)
Revenue
$ 0
Cost Of Revenue
$ 0
Gross Profit
$ 0
Operating Expenses
$ 0
Operating Income
$ 0
Interest Expense
$ 0
Pretax Income
$ 0
Net Income
$ 0
Income Tax Expense
$ 0
EBITDA
$ 0
Total Other Income Expense Net
$ 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2025-06-30)
Cash
$ 0
Short Term Investments
$ 0
Receivables
$ 0
Inventories
$ 0
Total Current Assets
$ 0
Property Plant Equipment
$ 0
Total Assets
$ 0
Payables
$ 0
Short Term Debt
$ 0
Long Term Debt
$ 0
Total Liabilities
$ 0
Equity
$ 0
(Last Updated 2025-06-30)
Net Income
$ 0
Depreciation
$ 0
Change In Working Capital
$ 0
Cash From Operations
$ 0
Capital Expenditures
$ 0
Cash From Investing
$ 0
Cash From Financing
$ 0
Net Change In Cash
$ 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.